Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial
Articolo
Data di Pubblicazione:
2011
Citazione:
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial / Vaglio, Augusto; Palmisano, Alessandra; Alberici, Federico; Maggiore, Umberto; Ferretti, Stefania; Cobelli, Rocco; Ferrozzi, Francesco; Corradi, Domenico; Salvarani, Carlo; Buzio, Carlo. - In: THE LANCET. - ISSN 0140-6736. - 378:9788(2011), pp. 338-346. [10.1016/S0140-6736(11)60934-3]
Abstract:
Glucocorticoids are the mainstay of treatment of idiopathic retroperitoneal fibrosis, but they often have substantial toxic effects. Several reports have suggested tamoxifen as an alternative to glucocorticoids. We compared the efficacy of prednisone with that of tamoxifen in maintainance of remission in patients with idiopathic retroperitoneal fibrosis.
Tipologia CRIS:
Articolo su rivista
Keywords:
Adolescent; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Remission Induction; Retroperitoneal Fibrosis; Secondary Prevention; Tamoxifen; Young Adult
Elenco autori:
Vaglio, Augusto; Palmisano, Alessandra; Alberici, Federico; Maggiore, Umberto; Ferretti, Stefania; Cobelli, Rocco; Ferrozzi, Francesco; Corradi, Domenico; Salvarani, Carlo; Buzio, Carlo
Link alla scheda completa:
Pubblicato in: